Neogen Chemicals Ltd is Rated Hold

Understanding the Current Rating

The 'Hold' rating assigned to Neogen Chemicals Ltd indicates a neutral stance for investors, suggesting that the stock is expected to perform in line with the market or sector averages in the near term. This rating reflects a balanced view of the company’s strengths and challenges, based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals.

Quality Assessment

As of 26 September 2026, Neogen Chemicals holds an average quality grade. The company’s ability to generate returns on shareholder equity remains modest, with an average Return on Equity (ROE) of 6.86%, signalling relatively low profitability per unit of shareholders’ funds. Additionally, the firm faces challenges in servicing its debt, evidenced by a high Debt to EBITDA ratio of 10.16 times. This elevated leverage ratio suggests a significant debt burden relative to earnings, which could constrain financial flexibility and growth prospects.

Despite these concerns, the company has demonstrated some operational resilience. Over the past five years, operating profit has grown at an annualised rate of 15.92%, indicating moderate long-term growth. However, this growth rate is tempered by the company’s debt servicing difficulties and modest profitability metrics.

Valuation Considerations

Neogen Chemicals is currently classified as very expensive in terms of valuation. The stock trades at an Enterprise Value to Capital Employed (EV/CE) ratio of 3.9, which is high relative to its return on capital employed (ROCE) of 5%. This disparity suggests that investors are paying a premium for the stock compared to the returns the company is generating on its capital base.

Nevertheless, the stock is trading at a discount compared to its peers’ average historical valuations, which may offer some relative value. Investors should weigh this premium valuation against the company’s growth prospects and profitability metrics when considering their investment decisions.

Financial Trend and Recent Performance

The latest data as of 26 September 2026 shows a mixed financial trend for Neogen Chemicals. The company reported positive quarterly results in June 2026 after four consecutive quarters of negative performance. Key highlights include a Profit After Tax (PAT) of ₹17.11 crores, representing a robust growth of 138.4% compared to the average of the previous four quarters. Net sales reached a record high of ₹250.29 crores, while PBDIT also hit a peak at ₹48.23 crores.

Despite these encouraging quarterly results, the company’s profits have declined by 17% over the past year. Meanwhile, the stock has delivered strong returns, with a 1-year return of 55.89% and a year-to-date gain of 100.95%. This divergence between stock price performance and profit trends highlights the importance of careful analysis before making investment decisions.

Technical Outlook

From a technical perspective, Neogen Chemicals exhibits a bullish trend. The stock has shown strong momentum recently, with a 6-month return of 98.04% and a 3-month gain of 27.00%. The one-day price change as of 26 September 2026 was +2.06%, reflecting positive investor sentiment and buying interest.

Technical strength can often signal continued upward price movement, but investors should remain cautious given the company’s fundamental challenges, particularly its high leverage and valuation concerns.

What This Rating Means for Investors

The 'Hold' rating on Neogen Chemicals Ltd suggests that investors should maintain their current positions rather than aggressively buying or selling the stock. The company’s average quality and positive financial trends are encouraging, but the very expensive valuation and high debt levels warrant caution.

Investors looking at Neogen Chemicals should monitor upcoming quarterly results and debt servicing metrics closely. Improvements in profitability and debt reduction could enhance the stock’s appeal, while any deterioration in these areas might increase risk.

Given the stock’s strong technical momentum, short-term traders may find opportunities to capitalise on price movements. However, long-term investors should weigh the fundamental challenges carefully before increasing exposure.

Sector and Market Context

Operating within the specialty chemicals sector, Neogen Chemicals faces competitive pressures and cyclical demand patterns. The sector often requires significant capital investment and is sensitive to raw material costs and regulatory changes. These factors contribute to the company’s elevated debt levels and valuation complexities.

Compared to broader market indices, Neogen Chemicals’ stock has outperformed significantly over the past year, with a 55.89% return versus more modest gains in many large-cap benchmarks. This outperformance reflects investor optimism but also raises questions about sustainability given the company’s fundamental profile.

Summary

In summary, Neogen Chemicals Ltd’s 'Hold' rating as of 25 May 2026 reflects a balanced view of its current position as of 26 September 2026. The company shows promising recent financial results and strong technical momentum, but faces challenges related to high leverage, modest profitability, and expensive valuation. Investors should consider these factors carefully when making portfolio decisions, recognising that the stock’s outlook is nuanced and requires ongoing monitoring.

Key Metrics at a Glance (As of 26 September 2026)

• Mojo Score: 64.0 (Hold)
• Debt to EBITDA Ratio: 10.16 times
• Return on Equity (avg): 6.86%
• Operating Profit Growth (5 years CAGR): 15.92%
• Enterprise Value to Capital Employed: 3.9
• ROCE: 5%
• 1-Year Stock Return: +55.89%
• Year-to-Date Stock Return: +100.95%
• Latest Quarterly PAT: ₹17.11 crores (138.4% growth vs previous 4Q average)
• Latest Quarterly Net Sales: ₹250.29 crores (highest recorded)
• Latest Quarterly PBDIT: ₹48.23 crores (highest recorded)

Investors should continue to track Neogen Chemicals’ financial health and market performance to assess whether the current 'Hold' rating remains appropriate in the evolving market environment.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →